In summary, our results show a higher frequency of MCA symptoms triggered by NSAIDs and other COXi in adult mastocytosis versus the general population, which are frequently associated with anaphylaxis and signs of more extensive disease, particularly among reactors to multiple drugs, in the absence of drug‐reaction‐associated deaths. Here, MT-CO1 is linked to anaphylaxis.